NEW THERAPEUTIC AGENTS

A compound of formula (I) or a compound of formula (II) or pharmaceutically acceptable salts thereof, wherein R1-R7 and X are as defined in the description, and the use of these compounds in therapy, in particular in treating cancer or as an inhibitor of the interaction of the MDM2 protein with p53....

Full description

Saved in:
Bibliographic Details
Main Authors HARDCASTLE IAN, ROBERT, GRIFFIN ROGER JOHN, GOLDING BERNARD, THOMAS, RIEDINGER CHRISTIANE, VALEUR ERIC, WATSON ANNA, FRANCES, NOBLE MARTIN
Format Patent
LanguageEnglish
French
Published 30.12.2009
Online AccessGet full text

Cover

More Information
Summary:A compound of formula (I) or a compound of formula (II) or pharmaceutically acceptable salts thereof, wherein R1-R7 and X are as defined in the description, and the use of these compounds in therapy, in particular in treating cancer or as an inhibitor of the interaction of the MDM2 protein with p53. L'invention concerne des composés représentés par la formule (I): ou des composés représentés par la formule (II) ou bien des sels de qualité pharmaceutique de ces composés, ainsi que leur utilisation thérapeutique, en particulier pour le traitement du cancer ou comme inhibiteur de l'interaction entre la protéine et MDM2 et p53.
Bibliography:Application Number: WO2009GB01599